Diabetes

>

Latest News

Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials
Efsitora Alfa, Eli Lilly’s Once Weekly Insulin, Has Positive Topline Results in Two Trials

September 6th 2024

Across two clinical trials in the QWINT program, once-wekly efsitora showed comparable A1C reduction to frequently used daily insulins.

FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes / Image credit: ©Araki Illustrations/AdobeStock
FDA Clears Tubeless Automated Insulin-Delivery System for Adults with Type 2 Diabetes

August 27th 2024

Type 1 Diabetes: The High Price of Not Knowing / image credit ©Beyond Type 1
Type 1 Diabetes: The High Price of Not Knowing

August 16th 2024

Intervention Cuts Alcohol Use in Youths with Chronic Medical Conditions: Daily Dose / image credit: ©New Africa/AdobeStock
Intervention Cuts Alcohol Use in Youths with Chronic Medical Conditions: Daily Dose

August 7th 2024

©goboystockphoto/stock.adobe.com
HbA1c Time in Range Shows Strong, Consistent Relationship with Dementia in Older Adults with Diabetes

August 5th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.